Boothbay Fund Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 1566 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 1633 |
|
|
2024
Q4 | – | Sell |
-8,970
| Closed | -$886K | – | 1733 |
|
|
2024
Q3 | $886K | Buy |
8,970
+3,945
| +79% | +$390K | 0.02% | 653 |
|
|
2024
Q2 | $466K | Buy |
+5,025
| New | +$466K | 0.01% | 879 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 1768 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 1848 |
|
|
2023
Q3 | – | Sell |
-10,873
| Closed | -$905K | – | 1878 |
|
|
2023
Q2 | $905K | Buy |
+10,873
| New | +$905K | 0.02% | 720 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 2222 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 2182 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 2336 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 2349 |
|
|
2022
Q1 | – | Sell |
-2,285
| Closed | -$256K | – | 2226 |
|
|
2021
Q4 | $256K | Sell |
2,285
-862
| -27% | -$96.6K | 0.01% | 1181 |
|
|
2021
Q3 | $396K | Buy |
+3,147
| New | +$396K | 0.01% | 997 |
|
|
2018
Q4 | – | Sell |
-12,500
| Closed | -$1.2M | – | 830 |
|
|
2018
Q3 | $1.2M | Buy |
+12,500
| New | +$1.2M | 0.12% | 112 |
|
|
2017
Q2 | – | Sell |
-7,400
| Closed | -$513K | – | 786 |
|
|
2017
Q1 | $513K | Buy |
+7,400
| New | +$513K | 0.1% | 202 |
|